Does the addition of high-dose vitamin D3 reduce the period of time required for the treatment of pulmonary tuberculosis?
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: This double-blind randomised placebo control trial investigated the addition of four doses of 2.5 mg of vitamin D3 to intensive phase antimicrobial therapy (isoniazid, rifampicin, pyrazinamide and ethambutol) for tuberculosis and the effect upon culture conversion rates. Time to conversion was measured at 14, 28, 42 and 56 days compared …
Source: Thorax
Author: J. Reed
Institution: South Tees Hospitals NHS Foundation Trust
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2106682189